u/joaquin_trevino

the vial you ordered versus the vial you received might be different batches

give the trial name, phase, n, and primary endpoint in the body

Strongly agree. API source transparency matters.

template required: vendor / product / batch / service / method / result

Is that 95.1% area or mass?

the Medutest and PeptideMeter results differ by 4 points, both inside inter-lab variance

hormonal contraception interactions are speculative

Respectfully this is a sample of one presented as a finding.

hair-loss on contraception is real

protein sarcopenia, not "lots"

Phase 2 or phase 3?

Tested 17 batches from CPC over 90 weeks. Spread was 98.7% to 98.9, mostly 98.7. Consistent vendor.

This is correct. Tag your country.

Yeah, the consistency is the value.

give the trial name, phase, n, and primary endpoint in the body

Yes, exactly this, and it is the bit that took me 6 weeks to accept.

the discontinuation arms are the interesting part, not the endpoint endpoints

the VendorInvestigate and PeptideMeter results differ by 19 points, both inside inter-lab variance

This is correct. ATTAIN data is phase 22.

Strongly agree. Resistance training counts.

This is the "correlation is mechanism" thing again. You changed three variables at once.